The Latest Cardiac and Vascular News
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today announced that it has signed an agreement to acquire Vesper Medical Inc., a US-based medical technology company that develops minimally-invasive peripheral vascular devices. Vesper Medical will further expand Philips’ portfolio of diagnostic and therapeutic devices […]
December 9, 2021 Philips’ next-generation nSIGHT Plus imaging architecture and new X5-1c Transthoracic Transducer drive breakthrough cardiac imaging performance Debut of AI-enhanced Auto Measure application helps reduce echo quantification time, improving patient and staff experience New remote access with diagnostic confidence on Collaboration Live solution extends the reach and efficiency of ultrasound […]
Philips showcases world’s first spectral detector angio-CT solution at RSNA 2021 Solution combines breakthrough spectral detector CT imaging and real-time fluoroscopy in a flexible environment where all modalities are operated through Philips Image-Guided Therapy System – Azurion with FlexArm Philips’ Spectral detector CT imaging in the interventional suite brings valuable […]
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today announced that it has signed an agreement to acquire Cardiologs, a France-based medical technology company focused on transforming cardiac diagnostics using artificial intelligence (AI) and cloud technology. Cardiologs will further strengthen Philips’ cardiac monitoring and […]
November 2, 2021 Philips debuts three new solutions in the North American market that will help drive procedural innovation and workflow efficiency, adding to the company’s ecosystem of interventional imaging systems, and diagnostic and therapeutic devices New clinical data presented at TCT 2021: five-year outcomes of iFR-SWEDEHEART trial and new large-scale […]
September 30, 2021 Unique five-year agreement will help Philadelphia-based health leader integrate and standardize innovative cardiovascular care, helping to deliver on the quadruple aim Amsterdam, the Netherlands and Philadelphia, PA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Lankenau Heart Institute part of Main Line Health, today announced they […]
Company’s innovative, integrated imaging systems, devices, software, informatics and services support greater efficiency, enabling high-quality care for a growing volume of complex cardiac patients Early detection, accurate diagnosis, precise treatment and easy follow-up are enabled by data-driven, streamlined workflows Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader […]
July 26, 2021 Second-quarter highlights Group sales increased to EUR 4.2 billion, with 9% comparable sales growth Comparable order intake decreased 15%, with strong double-digit growth in the Diagnosis & Treatment businesses and a decline in the Connected Care businesses on the back of COVID-19-related 167% growth in Q2 2020 […]
Rouen and Rennes, France, July 7, 2021 – Robocath, a company that designs, develops and commercializes robotic solutions to treat cardiovascular diseases, and Rennes University Hospital, today announce the launch of a co-development research program using robotics to improve treatment for stroke victims. With the support of Philips France, this unique […]
July 7, 2021 First patient enrolled in global multi-center randomized controlled trial with 564 patients at 15 sites comparing the impact of the Direct to Angio Suite workflow (diagnosis and treatment in the angio suite) to the conventional workflow (diagnosis in the CT or MRI suite followed by treatment in […]
